Literature DB >> 8996620

Postrenal transplant compliance from the perspective of African-Americans, Hispanic-Americans, and Anglo-Americans.

B R Siegal1, S M Greenstein.   

Abstract

Medication compliance by patients is a subject that has attracted attention because it has been identified as the third leading cause of renal graft loss. The purpose of this study was to gather specific information about renal-transplant recipients' cognitions, emotions, and behaviors during the postrenal transplant compliance process. Data from 519 renal transplant patients were collected through mailed surveys; chart audits were conducted for 397 patients in the sample. Findings revealed that 96 (18%) of the transplant recipients had been noncompliant with immunosuppressive medications. Factors related to noncompliance included being away from home, length of time since transplant, age, gender, and ethnicity, as well as patients' beliefs regarding how long posttransplant symptoms would persist and their beliefs about the effectiveness of immunosuppressive medications. Of particular interest were the findings related to compliance by African-American patients, which challenge conventional thinking. Implications for assessing patient compliance, patient education, and further research are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996620     DOI: 10.1016/s1073-4449(97)70016-5

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  14 in total

Review 1.  Issues of adherence to immunosuppressant therapy after solid-organ transplantation.

Authors:  Marie A Chisholm
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Can focusing on self-care reduce disparities in kidney transplantation outcomes?

Authors:  Elisa J Gordon; Thomas Prohaska; Laura A Siminoff; Peter J Minich; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

3.  A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients.

Authors:  Daniel Cukor; Nisha Ver Halen; Melissa Pencille; Fasika Tedla; Moro Salifu
Journal:  Nephron       Date:  2016-09-07       Impact factor: 2.847

4.  Conversion from Prograf to Advagraf in stable paediatric renal transplant patients and 1-year follow-up.

Authors:  Antonio J Carcas-Sansuán; Laura Espinosa-Román; Gonzalo N Almeida-Paulo; Angel Alonso-Melgar; Carmen García-Meseguer; Carlota Fernández-Camblor; Nicolás Medrano; Elena Ramirez
Journal:  Pediatr Nephrol       Date:  2013-08-02       Impact factor: 3.714

Review 5.  Medical adherence and liver transplantation: a brief review.

Authors:  Carl Hammond; Trana Hussaini; Eric M Yoshida
Journal:  Can Liver J       Date:  2021-02-24

6.  Medication-taking among adult renal transplant recipients: barriers and strategies.

Authors:  Elisa J Gordon; Mary Gallant; Ashwini R Sehgal; David Conti; Laura A Siminoff
Journal:  Transpl Int       Date:  2009-01-16       Impact factor: 3.782

Review 7.  Racial disparities in renal replacement therapy.

Authors:  Crystal Gadegbeku; Michele Freeman; Lawrence Agodoa
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

8.  Adherence to immunosuppression: a prospective diary study.

Authors:  E J Gordon; T R Prohaska; M P Gallant; L A Siminoff
Journal:  Transplant Proc       Date:  2007-12       Impact factor: 1.066

Review 9.  Medication noncompliance and its implications in transplant recipients.

Authors:  Paul E Morrissey; Michelle L Flynn; Sonia Lin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Once-daily tacrolimus extended-release formulation: 1 year after conversion in stable pediatric kidney transplant recipients.

Authors:  Lars Pape; Nele Heidotting; Thurid Ahlenstiel
Journal:  Int J Nephrol       Date:  2011-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.